Abbott Diabetes Care Inc. et al. vs DexCom, Inc.

Fed. Cir. Order Dismissing Appeal

Patent Owner's Notice of Cross-Appeal

Petitioner's Notice of Appeal

Decision on Request for Rehearing

Petitioner's Request for Rehearing

Errata on Final Written Decision

Final Written Decision: original

Other: Hearing transcript

Petitioner's Oral Argument Demonstratives

Patent Owner's Demonstrative Exhibits

Notice of Filing Patent Owner's Demonstrative Exhibits

Petitioner's Reply to Patent Owner's Opposition to Petitioner's Motion to Exclude Evidence

Order: Setting Oral Argument

Patent Owner's Opposition to Petitioner's Motion to Exclude

Petitioner's Motion to Exclude Evidence

Patent Owner's Sur-Reply

Petitioner's Request for Oral Argument

Patent Owner's Request for Oral Argument

Patent Owner's Third Updated Mandatory Notices

Petitioner's Updated Exhibit List

Patent Owner's Objections to Evidence Served with Petitioner's Reply

Petitioner's Reply to POR

Baura depo transcript, Day 1

Baura depo transcript, Day 2

Mastrototaro depo transcript

Petitioner's Notice of Deposition of Gail Baura, Ph.D.

Patent Owner's Second Updated Mandatory Notices

Notice of Stipulation of Further Change to Due Dates 2 & 3

Rehearing:Decision on Request for Rehearing

Petitioner's Objections to Evidence in Patent Owner Response

Declaration of Gail Baura

Curriculum Vitae of Gail Baura

Transcript of Deposition of John L. Smith, Ph.D. (Day 1) February 1, 2023

Transcript of Deposition of John L. Smith, Ph.D. (Day 2) February 2, 2023

Choleau et al., Biosens Bioelectron. 2002 Aug; 17(8):641-6

Choleau et al., Biosens Bioelectron. 2002 Aug; 17(8):647-54.

Koschwanez et al., Biomaterials. 2007 Sept; 28(25):3687-703.

Ward et al., Biosens Bioelectron. 2000 Mar; 15(1-2):53-61.

Lodwig et al., Diabetes Technol Ther. 2003; 5(4):572-86.

Koschinsky et al., Diabetes Metab Res Rev. 2001 Mar-Apr; 17(2):113-23.

Wilson et al., Biosens Bioelectron. 2005 Jun 15; 20(12):2388-403

Wisniewski et al., Am J Physiol Endocrinol Metab. 2002 Jun; 282(6):E1316-23.

Frost et al., Curr Opin Chem Biol. 2002 Oct; 6(5):633-41.

Abel et al., Biosens Bioelectron. 2002 Dec; 17(11-12):1059-70.

U.S. Patent Application Publication No. 2006/0281985

U.S. Provisional Patent Application No. 60/687,199

Pickup et al., Acta Diabetol. 1993; 30(3):143-8.

Pickup et al., BMJ. 1999 Nov 13; 319(7220):1289.

Kerner et al., Biosens Bioelectron. 1993;8(9-10):473-82.

U.S. Patent No. 8,396,670

Patent Owner's Response

Order: Denying POP Request

Patent Owner's Notice of Deposition of John L. Smith, Ph.D.

Notice of Joint Stipulation to Modify Due Dates 1-3

Ex. 3001 POP Request

Notice: notice of receipt of POP request

Petitioner's Objections to Patent Owner's Evidence Submitted with Patent Owner's Preliminary Response

Patent Owner's Objections to Evidence

Patent Owner's Request for Rehearing of Decision Granting Institution of Inter Partes Review

Institution Decision: Grant

EXPUNGED

Order: CASE MANAGEMENT AND SCHEDULING ORDER

Petitioner's Updated Mandatory Notices

Petitioner's Updated Exhibit List

Exhibit 1089 - Amended Scheduling Order

Patent Owner's Response to Petitioner's Explanation of Parallel Petitions

Patent Owner's Preliminary Response

Forlenza et al., Diabetes Technology and Therapeutics. (2019)

Vaddiraju et al., Journal of Diabetes Science and Technology. (2010)

Stephens Inc., Research Bulletin - DexCom, Inc. (March 28, 2018)

DexCom, Inc. v. Abbott Diabetes Care, Inc. et al., Case No. 6:21-cv-00690-ADA (W. D. Tex.), [Redacted Public Version] Defendants' Sealed Opening Claim Construction Brief (Mar. 23, 2022)

Hoss et al., Diabetes Technology and Therapeutics. (2017)

Patent Owner's First Update Mandatory Notices

PETITIONER'S UPDATED MANDATORY NOTICES UNDER 37 C.F.R. 42.8(a)(3)

Power of Attorney

Patent Owner's Mandatory Notices

Notice filing date accorded

PETITIONER���S EXPLANATION OF PARALLEL PETITIONS OF U.S. PATENT NO. 11,000,213 [CORRECTED]

U.S. Patent No. 11,000,213 ("'213 Patent")

Prosecution File History of the '213 Patent (Part 1 of 3)

Prosecution File History of the '213 Patent (Part 2 of 3)

Prosecution File History of the '213 Patent (Part 3 of 3)

U.S. Patent No. 6,275,717 to Gross et al. ("Gross")

WIPO Int'l Patent Application Publ'n No. WO 02/058537 A2 to Heller et al. ("Heller") (Part 1 of 2)

WIPO Int'l Patent Application Publ'n No. WO 02/058537 A2 to Heller et al. ("Heller") (Part 2 of 2)

Excerpts from the File History of Reexamination No. 95/001,039 of U.S. Patent No. 6,931,327 (Part 1 of 3)

Excerpts from the File History of Reexamination No. 95/001,039 of U.S. Patent No. 6,931,327 (Part 2 of 3)

Excerpts from the File History of Reexamination No. 95/001,039 of U.S. Patent No. 6,931,327 (Part 3 of 3)

First Amended Complaint for Patent Infringement in DexCom, Inc. v. Abbott Diabetes Care Inc., No. 6:21-cv-690 (W.D. Tex.) (Dkt. 19)

Excerpts from the File History of U.S. Patent No. 9,603,557

Chen et al., In Vivo Glucose Monitoring with Miniature "Wired" Glucose Oxidase Electrodes, 17 Analytical Sci. 2001 i297 (2001) (supplement) ("Chen-Heller")

U.S. Patent No. 9,603,557

U.S. Patent No. 7,905,833

Excerpts from the File History of U.S. Patent No. 9,775,543

Demonstrative Providing a Visual Representation of Priority Claims Related to U.S. Patent No. 10,993,642

Heller et al. Implanted Electrochemical Glucose Sensors for the Management of Diabetes, 1 Annu. Rev. Biomed. Eng. 153 (1999) ("Heller-1999")

U.S. Patent Publication No. 2005/0143635 to Kamath et al.

U.S. Patent No. 6,424,847 to Mastrototaro et al. ("Mastrototaro")

U.S. Patent No. 5,411,647 to Johnson et al. ("Johnson")

Nishida et al., Development of a Ferrocene-Mediated Needle-Type Glucose Sensor Covered with Newly Designed Biocompatible Membrane, 2-methacryloyloxyethyl phosphorylcholine -co-n-butyl methacrylate, 21 Medical Progress through Tech. 91 (1995) ("Nishida")

Heise et al. Hypoglycemia Warning Signal and Glucose Sensors: Requirements and Concepts, 5 Diabetes Technology & Therapeutics 563 (2003) ("Heise")

Excerpts from Stedman's Medical Dictionary 27th Ed. (2000) produced by DexCom in DexCom, Inc. v. Abbott Diabetes Care Inc., No. 6:21-cv-690 (W.D. Tex.)

Excerpts from Merriam-Webster's Medical Desk Dictionary (2002) produced by DexCom in DexCom, Inc. v. Abbott Diabetes Care Inc., No. 6:21-cv-690 (W.D. Tex.)

U.S. Patent No. 9,610,034 to Heller et al. ("Heller '034")

Excerpts from File History for U.S. Patent Application No. 14/936,577

Plaintiff DexCom Inc.'s Amended Preliminary Disclosure of Asserted Claims and Infringement Contentions to Abbott Diabetes Care, Inc.in DexCom, Inc. v. Abbott Diabetes Care Inc., No. 6:21-cv-690 (W.D. Tex.) (Jan. 5, 2022)

Letter from Defendants' Litigation Counsel to DexCom's Litigation Counsel Disclosing Proposed Constructions in DexCom, Inc. v. Abbott Diabetes Care Inc., No. 6:21-cv-690 (W.D. Tex.) (Feb. 22, 2022)

DexCom, Inc.'s Proposed Claim Constructions in DexCom, Inc. v. Abbott Diabetes Care Inc., No. 6:21-cv-690 (W.D. Tex.) (Feb. 2, 2022)

Email Chain Between Defendants' Litigation Counsel and DexCom's Litigation Counsel re DexCom's Proposed Constructions in DexCom, Inc. v. Abbott Diabetes Care Inc., No. 6:21-cv-690 (W.D. Tex.) (Mar. 1 - Mar. 10, 2022)

DexCom, Inc.'s Disclosure of Extrinsic Evidence in DexCom, Inc. v. Abbott Diabetes Care Inc., No. 6:21-cv-690 (W.D. Tex.) (Mar. 1, 2022)

Excerpt from Oxford English Dictionary (printout dated Feb. 24, 2022) produced by DexCom in DexCom, Inc. v. Abbott Diabetes Care Inc., No. 6:21-cv-690 (W.D. Tex.)

Excerpts from File History of U.S. Provisional Application No. 60/660,743

International Vocabulary of Basic and General Terms in Metrology (VIM) (2nd ed. 1993)

International Standard ISO 15195 Laboratory Medicine - Requirements for Reference Measurement Laboratories (1st ed. 2003-10-01)

Email Chain Between Defendants' Litigation Counsel and DexCom's Litigation Counsel re DexCom's Identification of Asserted Claims in DexCom, Inc. v. Abbott Diabetes Care Inc., No. 6:21-cv-690 (W.D. Tex.) (Nov. 30, 2021 - Jan. 5, 2022)

Lex Machina Data on Schedule of Judge Albright in the Western District of Texas

Andrew T. Dufresne, Nathan K. Kelley, & Lori Gordon, How reliable are trial dates relied on by the PTAB in the Fintiv analysis?, PERKINS COIE 1600 PTAB & BEYOND, Oct. 29, 2021

Dani Kass, Fintiv Fails: PTAB Uses 'Remarkably Inaccurate' Trial Dates, LAW360, Nov. 2, 2021

Excerpts from File History for U.S. Patent Application No. 12/683,755

Excerpts from File History for U.S. Patent Application No. 16/457,628

Excerpts from File History for U.S. Patent Application No. 16/691,252

Excerpts from File History for U.S. Patent Application No. 16/691,325

Excerpts from File History for U.S. Patent Application No. 15/787,595

Excerpts from File History for U.S. Patent Application No. 15/065,623

Excerpts from File History for U.S. Patent Application No. 13/607,162

Excerpts from File History for U.S. Patent Application No. 11/373,628

Excerpts from File History for U.S. Patent Application No. 16/690,977

Excerpts from File History for U.S. Patent Application No. 16/691,325

Excerpts from File History for U.S. Patent Application No. 16/691,252

Excerpts from File History for U.S. Patent Application No. 16/691,107

U.S. Patent No. 10,993,642 ("'642 Patent")

PETITION FOR INTER PARTES REVIEW OF CLAIMS 1, 4-6, 8, 20, 21, AND 23-26 OF U.S. PATENT NO. 11,000,213l

EXPUNGED

Expert Declaration of Dr. John L. Smith

Declaration of Sylvia D. Hall-Ellis, Ph.D

Power of Attorney